By Seth Borenstein

America’s honeybee hives just staggered through the second highest death rate on record, with beekeepers losing nearly half of their managed colonies, an annual bee survey found.

But using costly and Herculean measures to create new colonies, beekeepers are somehow keeping afloat. Thursday’s University of Maryland and Auburn University survey found that even though 48% of colonies were lost in the year that ended April 1, the number of United States honeybee colonies "remained relatively stable.”

Honeybees are crucial to the food supply, pollinating more than 100 of the crops we eat, including nuts, vegetables, berries, citrus and melons. Scientists said a combination of parasitespesticidesstarvation and climate change keep causing large die-offs.

Last year’s 48% annual loss is up from the previous year’s loss of 39% and the 12-year average of 39.6%, but it’s not as high as 2020-2021’s 50.8% mortality rate, the survey found. Beekeepers told the surveying scientists that 21% loss over the winter is acceptable and more than three-fifths of beekeepers surveyed said their losses were higher than that.

“This is a very troubling loss number when we barely manage sufficient colonies to meet pollination demands in the U.S.,” said former government bee scientist Jeff Pettis, president of the global beekeeper association Apimondia that wasn’t part of the study. “It also highlights the hard work that beekeepers must do to rebuild their colony numbers each year."

The overall bee colony population is relatively steady because commercial beekeepers split and restock their hives, finding or buying new queens, or even starter packs for colonies, said University of Maryland bee researcher Nathalie Steinhauer, the survey’s lead author. It's an expensive and time consuming process.

The prognosis is not as bad as 15 years ago because beekeepers have learned how to rebound from big losses, she said.

“The situation is not really getting worse, but it’s also not really getting better,” Steinhauer said. “It is not a bee apocalypse.”

Despite big annual losses the situation is a far cry from 2007 when many bee experts expected an end to managed pollination said U.S. Department Agriculture research entomologist Jay Evans, who wasn’t part of the survey.

“There are threats certainly in the environment and honeybees have persisted,” Evans said. “I don’t think honeybees will go extinct but I think they will always have these sort of challenges.”

Some commercial beekeepers who have succeeded in the past lost as much as 80% of their colonies this past year, while other beekeepers did well, it varied so much, Evans said. Pettis, who has 150 colonies on Maryland’s Eastern shore, had less than 18% loss, saying he used organic acids for mite control.

The parasitic mite Varroa destructor that helps transmit viruses is the chief culprit, but bad weather and queen issues were also big problems in the past year, Steinhauer said. Pesticides also make things worse because it makes bees more vulnerable to diseases and less likely to seek food, she said.

“It really can be like death by a thousand cuts with the most obvious one being varroa,” Steinhauer said.

The mite varroa is a flat creature that crawls on the bee – it would be the equivalent of a frisbee or flat softball on human bodies – Evans said. The mite seems to make it easier for viruses to attack and kill bees, he and Steinhauer said.

It used to take large amounts of varroa, such as in 60% of a colony, to cause virus problems, but now even small infestations at 1% or 2% in a colony can cause massive problems, Steinhauer said.

“We are fighting this evolving enemy,” Steinhauer said.

Another problem is landscapes that have only one crop or homogenous landscapes which deprive bees of food, while pesticides and bouts of extreme weather also have caused problems.

For example in the Washington, D.C. area unusual 80-degree warmth in January brought some bees out of their normal winter routine and then when it turned cool again, they had problems, Evans said.

“The impact of climate change on bee colony survival is real and can go undetected,” Pettis said in an email.

The demand for pollination from commercial bee colonies is growing even as the beekeepers have to work harder to make up for losses, Steinhauer said. The U.S. Department of Agriculture says 35% of the human diet comes from insect-pollinated plants and the honeybee is responsible for 80% of that pollination.

“There is this whole side of our agricultural industry that relies on these colonies,” Steinhauer said. “And the fact that every year the commercial beekeepers have to invest so much more effort to keep those numbers up because they have to fulfill those pollination contracts puts a lot of stress on those beekeepers and the bees.” ___

Share:
More In Science
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Nomi Health Closes $110 Million to Further Scale Its Direct Healthcare Model Nationwide
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
Delta Airlines CEO Calls for Shortened Quarantine Times Amid Staffing Shortage
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
NASA to Launch The James Webb Space Telescope on Christmas Eve
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
The Importance of COVID-19 Tests in the Age of Omicron
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
Load More